Sector
Pharma & Biotech
Novartis v. Natco imparts clarity on examination and opposition process under Patents Act being para...
31 May 2024In a decision dated January 9, 2024, the Delhi High Court clarified that the examination and opposition process, though statutorily structured to proceed parallelly, are independent and separate.
What should we know about the names of drugs?
31 May 2024When it comes to naming drugs, there’s more to consider than simply coming up with a snappy trade name. Ling Zhao and Qin Li explain how to navigate the three types of commercial identification of pharmaceuticals: the generic name, the trade name and...
Method of diagnosis and patentability in India
30 November 2023The Chinese University of Hong Kong and Sequenom, Inc. (the appellants) filed an appeal on October 12, 2023, with the High Court of Madras, praying the court to set aside the order dated March 31, 2021, passed by the respondent (the Indian Patent Off...